RecruitingNot Applicable

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

China60 participantsStarted 2019-09-29

Plain-language summary

To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort

Age range1 Month – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children acute leukemia Exclusion Criteria: * MODS

rate of UCB engraftment

Timeframe: initiate STR detection from day+15 thereafter weekly up to 1 year post-HSCT

rate of leukemia free survival

Timeframe: 3 years post-HSCT

rate of overall survival

Timeframe: 3 years post-HSCT

NCT IDNCT06155188

SponsorNanfang Hospital, Southern Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Yongsheng Ruan, MD